...Great. Good morning, everyone. My name is Jess Fye. I'm a biotech analyst at JPMorgan, and we're continuing the conference today with Alkermes. As you guys probably know, we're not switching for Q&A this year. If you want to ask a question during the Q&A session, just raise your hand, someone will bring you a microphone or alternatively, you can submit them electronically and I'll read them off the iPad. So with that, let me turn it over to Alkermes CEO, Richard Pops, for the presentation. Richard F. Pops ...